טוען...
SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularisation in a rat model of Retinopathy of Prematurity
PURPOSE: We tested the hypothesis that recombinant human VEGF-A(165)b and the serine arginine protein kinase (SRPK) inhibitor, SRPIN340, which controls splicing of the VEGF-A pre-mRNA, prevent neovascularisation in a rodent model of retinopathy of prematurity (ROP). METHODS: In the 50/10 oxygen-indu...
שמור ב:
| הוצא לאור ב: | Invest Ophthalmol Vis Sci |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6485497/ https://ncbi.nlm.nih.gov/pubmed/23761094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.13-11634 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|